Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Active, not recruiting · NCT03941730 · Registry updated 2026-05-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2026-05-12 | NCT03941730 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| National Cancer Institute (NCI) | 3015 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| FHCC South Lake Union | Seattle | United States | 16 |
| Mayo Clinic in Florida | Jacksonville | United States | 224 |
| Mayo Clinic in Rochester | Rochester | United States | 687 |
| MedStar Georgetown University Hospital | Washington D.C. | United States | 204 |
| Montefiore Medical Center-Einstein Campus | The Bronx | United States | 170 |
| UCSF Medical Center-Mission Bay | San Francisco | United States | 114 |
| University of Alabama at Birmingham Cancer Center | Birmingham | United States | 186 |
| University of Chicago Comprehensive Cancer Center | Chicago | United States | 273 |
| University of Washington Medical Center - Montlake | Seattle | United States | 121 |